A5045711669- Pharmaceutical studies and practices
- Drug Solubulity and Delivery Systems
- Crystallization and Solubility Studies
- Gastrointestinal motility and disorders
- Pediatric Pain Management Techniques
- Pharmaceutical Economics and Policy
- Gastroesophageal reflux and treatments
- Analytical Chemistry and Chromatography
- Antibiotics Pharmacokinetics and Efficacy
- Adolescent and Pediatric Healthcare
- Child and Adolescent Health
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Protein purification and stability
- Pharmacogenetics and Drug Metabolism
- Childhood Cancer Survivors' Quality of Life
- Drug Transport and Resistance Mechanisms
- Proteins in Food Systems
- Cystic Fibrosis Research Advances
- Esophageal and GI Pathology
- Pharmaceutical Practices and Patient Outcomes
- Pharmacological Effects and Toxicity Studies
- Analytical Methods in Pharmaceuticals
- Health Systems, Economic Evaluations, Quality of Life
- Helicobacter pylori-related gastroenterology studies
Illawarra Shoalhaven Local Health District
2025
University of Strathclyde
1996-2024
University of Virginia
2023
University of Birmingham
2013-2021
Therapeutics Clinical Research
2013
Heart of England NHS Foundation Trust
2011-2012
University College Hospital
2011
University College London
2011
Aston University
2004-2008
AstraZeneca (United Kingdom)
2008
Lipid nanoparticles have been widely investigated for their use as either carriers poorly water soluble actives or (Pickering) emulsion stabilisers. Recent studies suggested that the fabrication of lipid nanostructures can display both these performances concurrently, enable development liquid formulations multi-active encapsulation and release. Understanding effects different formulation variables on microstructural attributes underline functionalities is crucial in developing such...
Summary Background Gastro‐oesophageal reflux disease (GERD) is associated with a variety of typical and atypical symptoms. Patients often present in the first instance to pharmacist or primary care physician are subsequently referred secondary if initial management fails. Guidelines usually do not provide clear guidance for all healthcare professionals whom patient may consult. Aim To update 2002‐treatment algorithm GERD, making it more applicable pharmacists as well doctors. Methods A panel...
Abstract Despite several decades of research into encapsulation bacteria, most the proposed technologies are in form immobilized cultures. In this work, sporopollenin exine capsules (SECs) opened, using silica particles which act as pressing micro‐probes, and loaded with Lactobacillus casei ( L. ) cells, described for first time. The provided ≈30× higher yield (30.87%), compared to direct compression SECs (0.99%). Encapsulated cells show 1.21‐ 2.25‐folds viability free vitro simulated fasted...
Solid lipid nanoparticles and nanostructured carriers are two types of nanoparticulate systems, that have been primarily studied for their capability to function as active carriers, only more recently utilised in Pickering emulsion stabilisation. Unveiling the factors impact upon particle characteristics related functionality could enable development a liquid formulation with tailored microstructure potentially capacity display two-fold performance. In part I, this work investigates how...
In patients with gastric, gastroesophageal junction or esophageal adenocarcinoma (GOC), peri-operative multimodal therapies have improved survival; however, prognosis remains underwhelming. Pre-operative nutritional decline and weight are linked poorer patient outcomes. This study retrospectively analyzed the impact of status (as assessed by patient-generated subjective global assessment, PG-SGA), loss on survival undergoing curative surgery for GOC (2013 to 2022). Of 148 who underwent...